Organogenesis Holding (ORGO) Reports In-Line Q1 EPS; beats on guidance

Organogenesis Holding (NASDAQ: ORGO) reported Q1 EPS of ($0.02), in-line with the analyst estimate of ($0.02). Revenue for the quarter came in at $107.6 million versus the consensus estimate of $95.52 million.

GUIDANCE:

Organogenesis Holding sees FY2023 revenue of $454-466 million, versus the consensus of $454.8 million.

For earnings history and earnings-related data on Organogenesis Holding (ORGO) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Micron Technology (MU) PT Raised to $1,100 at Goldman Sachs
• Rheinmetall AG (RHM:GR) (RNMBY) PT Lowered to EUR1,750 at Morgan Stanley